Affimed N.V.
General ticker "AFMD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $44.3M (TTM average)
Affimed N.V. does not follow the US Stock Market performance with the rate: -11.4%.
Estimated limits based on current volatility of 17.3%: low 0.06$, high 0.08$
Factors to consider:
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.34$, 6.93$]
- 2024-12-30 to 2025-12-30 estimated range: [3.03$, 8.08$]
Financial Metrics affecting the AFMD estimates:
- Negative: Non-GAAP EPS, $ of -7.55 <= 0.04
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -65.49 <= 1.76
- Negative: Industry earnings per price (median), % of -30.69 <= 0
- Negative: negative Operating income
- Positive: Interest expense per share, $ of 0.13 <= 0.67
- Negative: Inventory ratio change, % of 15.40 > 1.03
- Negative: Industry operating cash flow per share per price (median), % of -25.05 <= 2.83
- Negative: negative Industry operating income (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -3.17 < Investing cash flow per share, $ of -2.66
Short-term AFMD quotes
Long-term AFMD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | €40.37MM | €41.35MM | €8.28MM |
| Operating Expenses | €104.40MM | €129.47MM | €114.94MM |
| Operating Income | €-64.03MM | €-88.12MM | €-106.66MM |
| Non-Operating Income | €6.51MM | €2.12MM | €0.73MM |
| Interest Expense | €0.71MM | €1.63MM | €1.81MM |
| R&D Expense | €81.49MM | €98.81MM | €94.96MM |
| Income(Loss) | €-57.52MM | €-86.00MM | €-105.94MM |
| Taxes | €0.00MM | €0.00MM | €0.00MM |
| Profit(Loss)* | €-57.52MM | €-86.00MM | €-105.94MM |
| Stockholders Equity | €135.95MM | €152.91MM | €57.81MM |
| Inventory | €0.42MM | €0.63MM | €0.46MM |
| Assets | €225.13MM | €200.51MM | €97.16MM |
| Operating Cash Flow | €-86.59MM | €-104.89MM | €-110.27MM |
| Capital expenditure | €3.85MM | €0.70MM | €3.73MM |
| Investing Cash Flow | €-3.85MM | €5.61MM | €-36.06MM |
| Financing Cash Flow | €133.58MM | €88.56MM | €-6.22MM |
| Earnings Per Share** | €-4.81 | €-6.04 | €-7.09 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.